Advanced search
Publication Cover
Future Oncology Volume 19, 2023 - Issue 13
Submit an article Journal homepage
2,007
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Real-World Outcomes in Metastatic HR+/HER2-, HER2+ and Triple Negative Breast Cancer after Start of First-Line Therapy

Richard W DeClue1 ConcertAI, 1120 Massachusetts Ave., Cambridge, MA02138,USAORCID Iconhttps://orcid.org/0000-0003-2968-9174View further author information
ORCID Icon,
Maxine D Fisher1 ConcertAI, 1120 Massachusetts Ave., Cambridge, MA02138,USAView further author information
,
Kyna Gooden2 Bristol-Myers Squibb, 3401 Princeton Pike, Lawrenceville,NJ08648,USAView further author information
,
Mark S Walker1 ConcertAI, 1120 Massachusetts Ave., Cambridge, MA02138,USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3276-2689View further author information
ORCID Icon &
Trong Kim Le2 Bristol-Myers Squibb, 3401 Princeton Pike, Lawrenceville,NJ08648,USAView further author information
Pages 909-923 | Received 09 Sep 2022, Accepted 13 Apr 2023, Published online: 16 May 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.